There has been a series of confusing studies over estrogen. Many menopausal women went off the drug when increased rates of breast cancer were found. However, recent findings are challenging this conventional wisdom as a “major government study has found that years after using estrogen-only therapy, certain women had a markedly reduced risk of breast cancer and heart attack,” according to The New York Times. The key, says Tara Parker-Pope, reporter for The New York Times, is that these women were only on estrogen, and not progestin. She explains the findings and what this means for women.
Our coverage reaches millions each week, but only a small fraction of listeners contribute to sustain our program. We still need 224 more people to donate $100 or $10/monthly to unlock our $67,000 match. Will you help us get there today?